Chronic myeloid leukemia following cyclophosphamide-containing chemotherapy in a breast cancer patient

Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: final analysis of efficacy and safety from the phase III CheckMate 214 trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

ESMO adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumours.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Genomic profiling in hepatocellular carcinoma: a real-world retrospective analysis.

ESMO open·2025

Longitudinal validation of the PROFFIT questionnaire to assess financial toxicity in cancer patients.

Journal of cancer policy·2025

Final analysis of nivolumab plus cabozantinib for advanced renal cell carcinoma from the randomized phase III CheckMate 9ER trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

The genomic landscape of metastatic clear-cell renal cell carcinoma and its prognostic value: a comprehensive analysis of a large real-world clinico-genomic database.

ESMO open·2025

Early measurement of ST2 and REG3α has a prognostic impact in haploidentical transplantation with post-transplant cyclophosphamide.

Haematologica·2026

The double-edged sword of Plasmodium falciparum: malaria and a predisposition to B-cell malignancy?

Haematologica·2026

Venetoclax plus azacitidine in younger adults with acute myeloid leukemia beyond historical comparisons. Comment on: "Venetoclax and azacitidine for younger acute myeloid leukemia patients independent of fitness for intensive chemotherapy".

Haematologica·2026

Beyond exclusion: the case for genetic screening in immune thrombocytopenia.

Haematologica·2026

Hyperinflammatory differentiation syndrome with hemophagocytic lymphohistiocytosis-like features following menin inhibition in acute myeloid leukemia.

Haematologica·2026

Neutrophil extracellular traps and DNase I levels in the bronchoalveolar lavage fluid of children with pulmonary injury after allogeneic hematopoietic stem cell transplantation: a TRANSPIRE study.

Haematologica·2026

When the Tumor Disappears, Must the Larynx Follow?

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Oncolytic Vaccinia Virus Armed With CLEC2A Enhances Antitumor Immunity via ROS-Autophagy Feedback Loop and Cytokine Activation.

Journal of medical virology·2026

Streptozotocin-based chemotherapy in advanced PanNETs: a systematic review and meta-analysis.

Endocrine-related cancer·2026

First-line osimertinib with or without chemotherapy for EGFR-mutant advanced NSCLC in China: a cost-effectiveness analysis.

Future oncology (London, England)·2026

Clinical predictors of treatment success following Gasserian ganglion conventional radiofrequency in trigeminal neuralgia: secondary cohort analysis.

Journal of oral & facial pain and headache·2026

[Scar tissue in the skin].

Ugeskrift for laeger·2026

Related Experiment Videos

Chronic myeloid leukemia following cyclophosphamide-containing chemotherapy in a breast cancer patient

Related Concept Videos

Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: final analysis of efficacy and safety from the phase III CheckMate 214 trial.

ESMO adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumours.

Genomic profiling in hepatocellular carcinoma: a real-world retrospective analysis.

Longitudinal validation of the PROFFIT questionnaire to assess financial toxicity in cancer patients.

Final analysis of nivolumab plus cabozantinib for advanced renal cell carcinoma from the randomized phase III CheckMate 9ER trial.

The genomic landscape of metastatic clear-cell renal cell carcinoma and its prognostic value: a comprehensive analysis of a large real-world clinico-genomic database.

Early measurement of ST2 and REG3α has a prognostic impact in haploidentical transplantation with post-transplant cyclophosphamide.

The double-edged sword of Plasmodium falciparum: malaria and a predisposition to B-cell malignancy?

Venetoclax plus azacitidine in younger adults with acute myeloid leukemia beyond historical comparisons. Comment on: "Venetoclax and azacitidine for younger acute myeloid leukemia patients independent of fitness for intensive chemotherapy".

Beyond exclusion: the case for genetic screening in immune thrombocytopenia.

Hyperinflammatory differentiation syndrome with hemophagocytic lymphohistiocytosis-like features following menin inhibition in acute myeloid leukemia.

Neutrophil extracellular traps and DNase I levels in the bronchoalveolar lavage fluid of children with pulmonary injury after allogeneic hematopoietic stem cell transplantation: a TRANSPIRE study.

When the Tumor Disappears, Must the Larynx Follow?

Oncolytic Vaccinia Virus Armed With CLEC2A Enhances Antitumor Immunity via ROS-Autophagy Feedback Loop and Cytokine Activation.

Streptozotocin-based chemotherapy in advanced PanNETs: a systematic review and meta-analysis.

First-line osimertinib with or without chemotherapy for EGFR-mutant advanced NSCLC in China: a cost-effectiveness analysis.

Clinical predictors of treatment success following Gasserian ganglion conventional radiofrequency in trigeminal neuralgia: secondary cohort analysis.

[Scar tissue in the skin].

Related Experiment Videos

Chronic myeloid leukemia following cyclophosphamide-containing chemotherapy in a breast cancer patient

Related Concept Videos

Related Articles